Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China
· Delayed Price · Currency is CNY 14.01
+0.12 (0.86%)
Mar 10, 2026, 3:04 PM CST
SHE:002275 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,161 | 8,866 | 8,514 | 7,570 | 9,728 | 8,577 | Upgrade
|
| Market Cap Growth | 0.22% | 4.14% | 12.46% | -22.18% | 13.41% | 12.23% | Upgrade
|
| Enterprise Value | 7,083 | 7,964 | 7,554 | 6,585 | 8,505 | 7,348 | Upgrade
|
| Last Close Price | 13.89 | 14.53 | 13.42 | 11.80 | 14.11 | 11.73 | Upgrade
|
| PE Ratio | 15.43 | 17.00 | 20.21 | 22.97 | 28.30 | 30.96 | Upgrade
|
| Forward PE | - | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 | Upgrade
|
| PS Ratio | 3.92 | 4.04 | 3.92 | 3.86 | 5.59 | 5.48 | Upgrade
|
| PB Ratio | 2.52 | 2.95 | 3.02 | 2.69 | 3.43 | 2.90 | Upgrade
|
| P/TBV Ratio | 2.63 | 3.10 | 3.20 | 2.87 | 3.66 | 3.08 | Upgrade
|
| P/FCF Ratio | 14.08 | 17.52 | 18.01 | 16.23 | 36.55 | 21.85 | Upgrade
|
| P/OCF Ratio | 10.38 | 15.07 | 15.50 | 14.32 | 23.71 | 14.34 | Upgrade
|
| EV/Sales Ratio | 3.40 | 3.63 | 3.48 | 3.36 | 4.88 | 4.69 | Upgrade
|
| EV/EBITDA Ratio | 13.04 | 13.94 | 13.13 | 15.98 | 20.59 | 18.67 | Upgrade
|
| EV/EBIT Ratio | 15.57 | 16.58 | 16.41 | 20.86 | 26.06 | 23.45 | Upgrade
|
| EV/FCF Ratio | 12.22 | 15.74 | 15.98 | 14.12 | 31.95 | 18.72 | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.20 | 0.19 | 0.17 | 0.21 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 1.17 | 1.01 | 0.92 | 1.08 | 1.41 | 1.03 | Upgrade
|
| Debt / FCF Ratio | 1.10 | 1.17 | 1.12 | 1.00 | 2.29 | 1.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.33 | -0.36 | -0.31 | -0.34 | -0.38 | -0.45 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.04 | -1.89 | -1.52 | -2.33 | -2.64 | -3.40 | Upgrade
|
| Net Debt / FCF Ratio | -1.86 | -2.14 | -1.86 | -2.06 | -4.10 | -3.41 | Upgrade
|
| Asset Turnover | 0.51 | 0.54 | 0.55 | 0.49 | 0.44 | 0.43 | Upgrade
|
| Inventory Turnover | 2.37 | 2.63 | 2.41 | 2.17 | 1.91 | 2.42 | Upgrade
|
| Quick Ratio | 2.75 | 2.33 | 2.09 | 2.39 | 2.56 | 3.60 | Upgrade
|
| Current Ratio | 3.13 | 2.58 | 2.46 | 2.71 | 2.96 | 4.04 | Upgrade
|
| Return on Equity (ROE) | 16.71% | 17.90% | 14.96% | 11.66% | 11.86% | 9.59% | Upgrade
|
| Return on Assets (ROA) | 6.91% | 7.35% | 7.28% | 4.90% | 5.11% | 5.37% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.14% | 20.13% | 19.74% | 12.95% | 15.51% | 14.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.00% | 14.80% | 15.10% | 10.10% | 10.00% | 9.50% | Upgrade
|
| Earnings Yield | 6.41% | 5.88% | 4.95% | 4.35% | 3.53% | 3.23% | Upgrade
|
| FCF Yield | 7.10% | 5.71% | 5.55% | 6.16% | 2.74% | 4.58% | Upgrade
|
| Dividend Yield | 3.96% | 4.13% | 4.47% | 6.78% | 6.38% | 3.41% | Upgrade
|
| Payout Ratio | 69.40% | 64.45% | 101.54% | 173.24% | 132.00% | 52.97% | Upgrade
|
| Buyback Yield / Dilution | 1.61% | -0.15% | 0.56% | -2.72% | 0.74% | 1.39% | Upgrade
|
| Total Shareholder Return | 5.55% | 3.98% | 5.03% | 4.06% | 7.11% | 4.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.